Amy K Feehan

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M Lagnf, Taylor Morrisette, Kyle C Molina, Alaina DeKerlegand, Melanie Rae Schrack, S Lena Kang-Birken, Athena L V Hobbs, Jazmin Agee, Nicholson B Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A King, Benjamin M Pullinger, Kimberly C Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P Veve, Bruce M Jones, Leonor M Rojas, Amy K Feehan, Marco R Scipione, Jing J Zhao, Paige Witucki, Michael Joseph Rybak
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022. Microbiology spectrum (2023)
Amy K Feehan, Kara D Denstel, Peter T Katzmarzyk, Cruz Velasco, Jeffrey H Burton, Eboni G Price-Haywood, Leonardo Seoane
Community versus individual risk of SARS-CoV-2 infection in two municipalities of Louisiana, USA: An assessment of Area Deprivation Index (ADI) paired with seroprevalence data over time. PloS one 16 (11) (2021)

Amy K Feehan.css-eqlu8i{font-size:small;padding-left:4px;}